Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study

FM Uckun, PG Steinherz, H Sather, M Trigg, D Arthur, D Tubergen, P Gaynon, G Reaman

Blood (1996) 88 (11): 4288–4295.

https://doi.org/10.1182/blood.V88.11.4288.4288

Published: 1996

Journal Articles

Severe combined immunodeficient mouse models of human leukemia

FM Uckun

Blood (1996) 88 (4): 1135–1146.

https://doi.org/10.1182/blood.V88.4.1135.bloodjournal8841135

Published: 1996

Journal Articles

In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells

KG Waddick, DE Myers, R Gunther, LM Chelstrom, M Chandan-Langlie, JD Irvin, N Tumer, FM Uckun

Blood (1995) 86 (11): 4228–4233.

https://doi.org/10.1182/blood.V86.11.4228.bloodjournal86114228

Published: 1995

Journal Articles

In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells

FM Uckun, CF Stewart, G Reaman, LM Chelstrom, J Jin, M Chandan-Langlie, KG Waddick, J White, WE Evans

Blood (1995) 85 (10): 2817–2828.

https://doi.org/10.1182/blood.V85.10.2817.bloodjournal85102817

Published: 1995

Journal Articles

Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)- pokeweed antiviral protein immunotoxin

R Gunther, LM Chelstrom, L Tuel-Ahlgren, J Simon, DE Myers, FM Uckun

Blood (1995) 85 (9): 2537–2545.

https://doi.org/10.1182/blood.V85.9.2537.bloodjournal8592537

Published: 1995

Journal Articles

Leukemic cell growth in SCID mice as a predictor of relapse in high- risk B-lineage acute lymphoblastic leukemia

FM Uckun, H Sather, G Reaman, J Shuster, V Land, M Trigg, R Gunther, L Chelstrom, A Bleyer, P Gaynon

Blood (1995) 85 (4): 873–878.

https://doi.org/10.1182/blood.V85.4.873.bloodjournal854873

Published: 1995

Journal Articles

Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency

FM Uckun, JR Downing, LM Chelstrom, R Gunther, M Ryan, J Simon, AJ Carroll, L Tuel-Ahlgren, WM Crist

Blood (1994) 84 (3): 859–865.

https://doi.org/10.1182/blood.V84.3.859.859

Published: 1994

Journal Articles

Childhood acute myeloid leukemia in mice with severe combined immunodeficiency

LM Chelstrom, R Gunther, J Simon, SC Raimondi, R Krance, WM Crist, FM Uckun

Blood (1994) 84 (1): 20–26.

https://doi.org/10.1182/blood.V84.1.20.20

Published: 1994

Journal Articles

Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase- dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes

GL Schieven, JM Kirihara, DE Myers, JA Ledbetter, FM Uckun

Blood (1993) 82 (4): 1212–1220.

https://doi.org/10.1182/blood.V82.4.1212.1212

Published: 1993

Journal Articles

Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency

FM Uckun, JR Downing, R Gunther, LM Chelstrom, D Finnegan, VJ Land, MJ Borowitz, AJ Carroll, WM Crist

Blood (1993) 81 (11): 3052–3062.

https://doi.org/10.1182/blood.V81.11.3052.3052

Published: 1993

Journal Articles

Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts

FM Uckun, CW Song

Blood (1993) 81 (5): 1323–1332.

https://doi.org/10.1182/blood.V81.5.1323.1323

Published: 1993

Journal Articles

G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells

PM Anderson, W Crist, D Hasz, AJ Carroll, DE Myers, FM Uckun

Blood (1992) 80 (11): 2826–2834.

https://doi.org/10.1182/blood.V80.11.2826.2826

Published: 1992

Journal Articles

Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide

FM Uckun, LM Chelstrom, D Finnegan, L Tuel-Ahlgren, C Manivel, JD Irvin, DE Myers, R Gunther

Blood (1992) 79 (12): 3116–3129.

https://doi.org/10.1182/blood.V79.12.3116.3116

Published: 1992

Journal Articles

Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein

FM Uckun, S Haissig, JA Ledbetter, P Fidler, DE Myers, V Kuebelbeck, D Weisdorf, K Gajl-Peczalska, JH Kersey, NK Ramsay

Blood (1992) 79 (12): 3369–3379.

https://doi.org/10.1182/blood.V79.12.3369.3369

Published: 1992

Journal Articles

In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia

FM Uckun, LM Chelstrom, JD Irvin, D Finnegan, R Gunther, J Young, V Kuebelbeck, DE Myers, LL Houston

Blood (1992) 79 (10): 2649–2661.

https://doi.org/10.1182/blood.V79.10.2649.2649

Published: 1992

Journal Articles

In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency

FM Uckun, C Manivel, D Arthur, LM Chelstrom, D Finnegan, L Tuel-Ahlgren, JD Irvin, DE Myers, R Gunther

Blood (1992) 79 (9): 2201–2214.

https://doi.org/10.1182/blood.V79.9.2201.2201

Published: 1992

Journal Articles

Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4- hydroperoxycyclophosphamide for ex vivo bone marrow purging

FM Uckun, JH Kersey, R Haake, D Weisdorf, NK Ramsay

Blood (1992) 79 (4): 1094–1104.

https://doi.org/10.1182/blood.V79.4.1094.1094

Published: 1992

Journal Articles

In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia

FM Uckun, NK Ramsay, KG Waddick, W Jaszcz, M Chandan-Langlie, V Obuz, R Haake, K Gajl-Peczalska, JH Kersey, CW Song

Blood (1991) 78 (11): 2945–2955.

https://doi.org/10.1182/blood.V78.11.2945.2945

Published: 1991

Journal Articles

Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells

I Dibirdik, MC Langlie, JA Ledbetter, L Tuel-Ahlgren, V Obuz, KG Waddick, K Gajl-Peczalska, GL Schieven, FM Uckun

Blood (1991) 78 (3): 564–570.

https://doi.org/10.1182/blood.V78.3.564.564

Published: 1991

Journal Articles

Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination

KG Waddick, CW Song, L Souza, FM Uckun

Blood (1991) 77 (11): 2364–2371.

https://doi.org/10.1182/blood.V77.11.2364.2364

Published: 1991

NARROW

CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study

Severe combined immunodeficient mouse models of human leukemia

In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells

In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells

Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)- pokeweed antiviral protein immunotoxin

Leukemic cell growth in SCID mice as a predictor of relapse in high- risk B-lineage acute lymphoblastic leukemia

Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency

Childhood acute myeloid leukemia in mice with severe combined immunodeficiency

Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase- dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes

Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency

Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts

G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells

Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide

Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein

In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia

In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency

Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4- hydroperoxycyclophosphamide for ex vivo bone marrow purging

In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia

Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells

Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only